Meral Kayikcioglu/
Dec 3, 2025, 02:29
Meral Kayikcioglu: Successfully Completing FDA Inspections for Two Phase 3 Trials
Meral Kayikcioglu, Professor of Cardiology at Ege University and Director of the Lipid and Prevention Clinic, shared on LinkedIn:
“We successfully completed FDA inspections for two different Phase 3 RCTs (LIB-HoFH and HeFH)! This extremely challenging and prestigious inspection in pharmaceutical R&D processes also demonstrated our compliance with global standards.
To my knowledge, only 10 FDA inspections have been conducted in our country to date. Successfully passing one of these inspections is a source of great pride for both our team and our country. I thank all my teammates and stakeholders who contributed to this process.
We continue to work for stronger, more innovative, and more reliable science!”
Stay updated with Hemostasis Today.
-
Apr 21, 2026, 21:07Tareq Abadl: Not Every Low Platelet Count Is True – Check the Smear First
-
Apr 21, 2026, 21:05Beverley Hunt: Honored to Receive the Lifetime Achievement Award at BSH 2026
-
Apr 21, 2026, 21:03Toong Youttananukorn: Proud to Support Data That Drives Action at WFH 2026
-
Apr 21, 2026, 20:48Ney Carter Borges: Endothelial Senescence as a Central Driver of Adipose Dysfunction in Heart Failure and Type 2 Diabetes
-
Apr 21, 2026, 20:29Can Stem Cell-Delivered Platelets Fight Drug-Resistant Bacteria?- RPTH Journal
-
Apr 21, 2026, 18:51WHO Expert Lorenzo Moja Discusses How Essential Medicines Policy Expands Access to Treatment – WFH
-
Apr 21, 2026, 18:35Ana Pedrero Gil: New ASH–ISTH 2026 Guidelines Focus on Preventing VTE in Children
-
Apr 21, 2026, 17:36Sip Wijchers: Is It Time to Use Ultrasound for Every AF Ablation Access?
-
Apr 21, 2026, 16:32Sarah Walbolt։ Have You Ever Wondered What Actually Happens to Your Donated Blood?